ClinicalTrials.Veeva

Menu

Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section

M

Mahidol University

Status

Completed

Conditions

Morphine Adverse Reaction

Treatments

Drug: normal saline
Drug: naloxone

Study type

Interventional

Funder types

Other

Identifiers

NCT00890942
Si146/2009

Details and patient eligibility

About

The purpose of this study is to determine whether intramuscular naloxone 0.4mg. is effective in prophylaxis of intrathecal morphine induced pruritus after cesarean section.

Enrollment

60 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient schedule for cesarean section ASA class 1

Exclusion criteria

  • have contraindication for spinal block
  • complicated pregnancy
  • have history of drug abuse during pregnancy
  • obesity BMI>35kg./m2

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

naloxone
Experimental group
Treatment:
Drug: naloxone
normal saline
Placebo Comparator group
Treatment:
Drug: normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems